Hypersensitivities to non-steroidal anti-inflammatory drugs

References

• Kowalski ML, Makowska JS, Blanca M, et al. Hypersensitivity to nonsteroidal antiinflammatory drugs (NSAIDs) – classification, diagnosis and management: review of the EAACI/ENDA and GA2LEN/HANNA. Allergy 2011;66:818-29
   PubMed Web of Science ®Google Scholar
• Howard RL, Avery AJ, Slavenburg S, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmaocl 2007;63:136-47
   PubMed Web of Science ®Google Scholar
• Kowalski ML, Asero R, Bavbek S, et al. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy 2013;68(10):1219-32
   PubMed Web of Science ®Google Scholar
• Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ 2004;328:434-7
   PubMed Web of Science ®Google Scholar
• Weber RW, Hoffman M, Raine DA Jr, Nelson HS. Incidence of bronchoconstriction due to aspirin, azo dyes, non-azo dyes, and preservatives in a population of perennial asthmatics. J Allergy Clin Immunol 1979;64:32-7
   PubMed Web of Science ®Google Scholar
• Hedman J, Kaprio J, Poussa T, Nieminen MM. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol 1999;28:717-22
   PubMed Web of Science ®Google Scholar
• Samter M, Beers RF Jr. Intolerance to aspirin: clinical studies and consideration of its pathogenesis. Ann Intern Med 1968;68:975-83
   PubMed Web of Science ®Google Scholar
• Berges-Gimeno M, Simon RA, Stevenson DD. Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2003;111:180-6
   PubMed Web of Science ®Google Scholar
• Fahrenholz JM. Natural history and clinical features of aspirin-exacerbated respiratory disease. Clin Rev Allergy Immunol 2003;24(2):113-24
   PubMed Web of Science ®Google Scholar
• Karakaya G, Celebioglu E, Kalyoncu AF. Non-steroidal anti-inflammatory drug hypersensitivity in adults and the factors associated with asthma. Respir Med 2013;107(7):967-74
   PubMed Web of Science ®Google Scholar
• Ying S, Meng Q, Scadding G, et al. Aspirin-sensitive rhinosinusitis is associated with reduced E-prostanoid 2 receptor expression on nasal mucosal inflammatory cells. J Allergy Clin Immunol 2006;117(2):312-18
   PubMed Web of Science ®Google Scholar
• Kowalski ML, Pawliczak R, Wozniak J, et al. Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients. Am J Respir Crit Care Med 2000;161(2 Pt 1):391-8
   PubMed Web of Science ®Google Scholar
• Park H, Kowalski M, Sanchez-Borges M. Hypersensitivity to aspirin and nonsteroidal antiinflammatory drugs. In: Adkinson N, Bochner BS, Burks AW, Busse WW, Holgate ST, Lemanske RF, O’Hehir RE, editors. Middleton’s allergy. 8th edition. Saunders Elsevier; PA, USA: 2013. p. 1296-309
   Google Scholar
• Casadevall J, Ventura PJ, Mullol J, Picado C. Intranasal challenge with aspirin in the diagnosis of aspirin intolerant asthma: evaluation of nasal response by acoustic rhinometry. Thorax 2000;55:921-4
   PubMed Web of Science ®Google Scholar
• White A, Bigby T, Stevenson D. Intranasal ketorolac challenge for the diagnosis of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 2006;97:190-5
   PubMed Web of Science ®Google Scholar
• Lee RU, White AA, Ding D, et al. Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 2010;105:130-5
   PubMed Web of Science ®Google Scholar
• Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, et al. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy 2007;62:1111-18
   PubMed Web of Science ®Google Scholar
• Mathison DA, Lumry WR, Stevenson DD, et al. Aspirin in chronic urticaria and/or angioedema: studies of sensitivity and desensitization. J Allergy Clin Immunol 1982;69:135-40
   Google Scholar
• Zembowicz A, Mastalerz L, Setkowicz M, et al. Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs. Arch Dermatol 2003;139:1577-82
   PubMed Web of Science ®Google Scholar
• Mastalerz L, Setkowicz M, Sanak M, Szczeklik A. Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma. J Allergy Clin Immunol 2004;113:771-5
   PubMed Web of Science ®Google Scholar
• Layton D, Marshall V, Boshiek A, et al. Serious skin reactions and selective COX-2 inhibitors: a case series from prescription-event monitoring in England. Drug Saf 2006;29:687-96
   PubMed Web of Science ®Google Scholar
• Ward KE, Archambault R, Mersfelder JL. Severe adverse reactions to nonsteroidal antiinflammatory drugs: a review of the literature. Am J Health Syst Pharm 2010;67:206-13
   Google Scholar
• Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 2004;59:809-20
   PubMed Web of Science ®Google Scholar
• Cryer B, Feldman M. Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans. Gastroenterology 1999;117:17-25
   PubMed Web of Science ®Google Scholar
• Tarazi EM, Harter JG, Zimmerman HJ, et al. Sulindac-associated hepatic injury: analysis of 91 cases reported to the Food and Drug Administration. Gastroenterology 1993;104(2):569-74
   Google Scholar
• Patrono C, Dunn MJ. The clinical significance of inhibition of renal prostaglandin synthesis. Kidney Int 1987;32:1-12
   PubMed Web of Science ®Google Scholar
• Bhala N, Emberson J, Merhi A, et al. Vascular and upper gastrointestinal effects of nonsteroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomized trials. Lancet 2013;382:769-79
   PubMed Web of Science ®Google Scholar
• Strom BL, Carson JL, Schinnar R, et al. Nonsteroidal anti-inflammatory drugs and neutropenia. Arch Intern Med 1993;153:2119-24
   PubMed Web of Science ®Google Scholar
• Patrono C. Aspirin as an antiplatelet drug. N Engl J Med 1994;330:1287-94
   PubMed Web of Science ®Google Scholar
• Simon LS, Mills JA. Drug therapy: nonsteroidal antiinflammatory drugs (first of two parts). N Engl J Med 1980;302:1179-85
   PubMed Web of Science ®Google Scholar
• Macy E, Bernstein JA, Castells MC, et al. Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper. Ann Allergy Asthma Immunol 2007;98:172-4
   PubMed Web of Science ®Google Scholar
• Berges-Gimeno MP, Simon RA, Stevenson DD. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 2002;89(5):474-8
   PubMed Web of Science ®Google Scholar